Not Here to Defend Steve..... .....and in spite of a failure by some to do anything but blame others for their losses the junior markets are what they are. Having said that it is obviously clear that Steve (and many investors) realized or have recently come to the conclusion that bricks and mortar clinic expansion without significant capital was mired in uncertainty in spite of best intentions ....especially if the humble beginnings were in Canada. Some, including me, looked too far ahead to expansion into the US ....the proverbial cart before the horse. Covid didn't help this and thank goodness Medisure was acquired.
While the road is uncertain for me it was a time to average down and try to recoup. Having bought, sold and bought some shares between $.02 and $.07 the average is now $.065 ...
with a lot more shares. By diversifying into dividend generating stock there is now free capital to invest.
The road travelled for any stock on the TSXV is fraught with "crazy", unpredictability and uncertainty. Whether Steve can inspire confidence again has and is always based on a personal sentiment and DD. Moving toward sole distribution rights for diagnostic products specifically in the US market appears a move in the right direction.